322 related articles for article (PubMed ID: 18278839)
1. Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus.
Qazi U; Lam C; Karumanchi SA; Petri M
J Rheumatol; 2008 Apr; 35(4):631-4. PubMed ID: 18278839
[TBL] [Abstract][Full Text] [Related]
2. Circulating Angiogenic Factors and the Risk of Preeclampsia in Systemic Lupus Erythematosus Pregnancies.
Leaños-Miranda A; Campos-Galicia I; Berumen-Lechuga MG; Molina-Pérez CJ; García-Paleta Y; Isordia-Salas I; Ramírez-Valenzuela KL
J Rheumatol; 2015 Jul; 42(7):1141-9. PubMed ID: 25979720
[TBL] [Abstract][Full Text] [Related]
3. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
[TBL] [Abstract][Full Text] [Related]
4. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
[TBL] [Abstract][Full Text] [Related]
5. Circulating angiogenic factors and the risk of preeclampsia.
Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
[TBL] [Abstract][Full Text] [Related]
6. Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy.
Gurnadi JI; Mose J; Handono B; Satari MH; Anwar AD; Fauziah PN; Yogi Pramatirta A; Rihibiha DD
BMC Res Notes; 2015 Oct; 8():534. PubMed ID: 26434493
[TBL] [Abstract][Full Text] [Related]
7. Soluble Flt-1, Placental Growth Factor, and Vascular Endothelial Growth Factor Serum Levels to Differentiate Between Active Lupus Nephritis During Pregnancy and Preeclampsia.
de Jesús GR; Lacerda MI; Rodrigues BC; Dos Santos FC; do Nascimento AP; Cristóvão Porto L; de Jesús NR; Levy RA; Klumb EM
Arthritis Care Res (Hoboken); 2021 May; 73(5):717-721. PubMed ID: 32583963
[TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of serum levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio to rule out preeclampsia in women with new-onset lupus nephritis during pregnancy.
Hirashima C; Ogoyama M; Abe M; Shiraishi S; Sugase T; Niki T; Matsubara S; Ohkuchi A
CEN Case Rep; 2019 May; 8(2):95-100. PubMed ID: 30565047
[TBL] [Abstract][Full Text] [Related]
9. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
[TBL] [Abstract][Full Text] [Related]
11. Interferon-α and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia.
Andrade D; Kim M; Blanco LP; Karumanchi SA; Koo GC; Redecha P; Kirou K; Alvarez AM; Mulla MJ; Crow MK; Abrahams VM; Kaplan MJ; Salmon JE
Arthritis Rheumatol; 2015 Apr; 67(4):977-87. PubMed ID: 25603823
[TBL] [Abstract][Full Text] [Related]
12. Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women.
Forest JC; Thériault S; Massé J; Bujold E; Giguère Y
Clin Chem Lab Med; 2014 Aug; 52(8):1169-78. PubMed ID: 24535301
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of preeclampsia with soluble Fms-like tyrosine kinase 1/placental growth factor ratio: an inter-assay comparison.
Andersen LB; Frederiksen-Møller B; Work Havelund K; Dechend R; Jørgensen JS; Jensen BL; Nielsen J; Lykkedegn S; Barington T; Christesen HT
J Am Soc Hypertens; 2015 Feb; 9(2):86-96. PubMed ID: 25600419
[TBL] [Abstract][Full Text] [Related]
14. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.
Shibata E; Rajakumar A; Powers RW; Larkin RW; Gilmour C; Bodnar LM; Crombleholme WR; Ness RB; Roberts JM; Hubel CA
J Clin Endocrinol Metab; 2005 Aug; 90(8):4895-903. PubMed ID: 15886253
[TBL] [Abstract][Full Text] [Related]
15. Analytical evaluation of the novel soluble fms-like tyrosine kinase 1 and placental growth factor assays for the diagnosis of preeclampsia.
van Helden J; Weiskirchen R
Clin Biochem; 2015 Nov; 48(16-17):1113-9. PubMed ID: 26129879
[TBL] [Abstract][Full Text] [Related]
16. Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies.
Dröge L; Herraìz I; Zeisler H; Schlembach D; Stepan H; Küssel L; Henrich W; Galindo A; Verlohren S
Ultrasound Obstet Gynecol; 2015 Mar; 45(3):286-93. PubMed ID: 25491901
[TBL] [Abstract][Full Text] [Related]
17. Angiogenic factors in pregnancies of women with antiphospholipid syndrome and systemic lupus erythematosus.
Mayer-Pickel K; Stern C; Eberhard K; Lang U; Obermayer-Pietsch B; Cervar-Zivkovic M
J Reprod Immunol; 2018 Jun; 127():19-23. PubMed ID: 29689494
[TBL] [Abstract][Full Text] [Related]
18. Clinical Assessment of Soluble FMS-Like Tyrosine Kinase-1/Placental Growth Factor Ratio for the Diagnostic and the Prognosis of Preeclampsia in the Second Trimester.
Chelli D; Hamdi A; Saoudi S; Jenayah AA; Zagre A; Jguerim H; Bedis C; Sfar E
Clin Lab; 2016 Oct; 62(10):1927-1932. PubMed ID: 28164532
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia.
Ohkuchi A; Hirashima C; Suzuki H; Takahashi K; Yoshida M; Matsubara S; Suzuki M
Hypertens Res; 2010 May; 33(5):422-7. PubMed ID: 20150910
[TBL] [Abstract][Full Text] [Related]
20. Serum soluble FMS-like tyrosine kinase 1 and placental growth factor concentration as predictors of preeclampsia in high risk pregnant women.
Hanita O; Alia NN; Zaleha AM; Nor Azlin MI
Malays J Pathol; 2014 Apr; 36(1):19-26. PubMed ID: 24763231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
